aaiPharma pain franchise
Executive Summary
AaiPharma plans to develop line extensions for Darvon (propoxyphene) and Darvocet (propoxyphene and acetaminophen) following agreement to acquire U.S. rights from Lilly for $211.4 mil. Darvon and Darvocet, indicated for mild to moderate pain, had combined net sales of $62.9 mil. in 2001...